Spots Global Cancer Trial Database for Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy

Official Title: Evaluating a Clinician Support Algorithm to Enhance Implementation of Evidence-Based Chemotherapy-Induced Peripheral Neuropathy Assessment and Management Recommendations

Study ID: NCT03514680

Conditions

Cancer

Chemotherapy-induced Peripheral Neuropathy

Interventions

CIPN Assessment and Management Algorithm

Study Description

Brief Summary: This research study is evaluating how well a decision support tool works to improve clinicians' use of recommended chemotherapy-induced peripheral neuropathy (CIPN) assessment and management strategies in participants receiving chemotherapy.

Detailed Description: This research study will test a new clinician decision support tool for the assessment and management of CIPN. The algorithm is designed to help clinicians make decisions about which strategies to use for the assessment and/or management of CIPN. The investigators need to recruit participants receiving chemotherapy that is known to cause CIPN to determine how well the algorithm works to increase clinicians' use of recommended CIPN assessment and management strategies.